• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.01%

    TrovaGene, Inc. (TROV)

    -NasdaqCM
    7.88 Up 0.07(0.90%) Jul 31, 4:00PM EDT
    |After Hours : 7.88 0.00 (0.00%) Jul 31, 4:43PM EDT
    Add to Portfolio
    Prev Close:7.81
    Open:7.80
    Bid:7.88 x 1000
    Ask:8.26 x 100
    1y Target Est:11.00
    Beta:-0.16
    Next Earnings Date:10-Aug-15TROV Earnings announcement
    Day's Range:7.70 - 8.09
    52wk Range:3.00 - 13.58
    Volume:928,904
    Avg Vol (3m):709,638
    Market Cap:228.46M
    P/E (ttm):N/A
    EPS (ttm):-1.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TROV

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):644.82
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.09
    Quarterly EPS Est (Jun-15) :-0.24
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trovagene, Inc., a molecular diagnostic company, focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback